A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

NCT00620074 ·Status: TERMINATED ·Phase: PHASE4

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

NCT00412893 ·Status: COMPLETED ·Phase: PHASE3

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

NCT00001810 ·Status: COMPLETED ·Phase: PHASE3

A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

NCT00836875 ·Status: TERMINATED ·Phase: PHASE3

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

NCT00003031 ·Status: COMPLETED ·Phase: PHASE3

Azole-echinocandin Combination Therapy for Invasive Aspergillosis

NCT04876716 ·Status: TERMINATED ·Phase: PHASE3

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

NCT00163111 ·Status: COMPLETED ·Phase: PHASE3

Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects

NCT01188759 ·Status: WITHDRAWN ·Phase: PHASE3

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

NCT02646800 ·Status: TERMINATED ·Phase: PHASE4

Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects

NCT04872231 ·Status: COMPLETED ·Phase: PHASE1

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

NCT00531479 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)

NCT01782131 ·Status: COMPLETED ·Phase: PHASE3

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

NCT02646774 ·Status: TERMINATED ·Phase: PHASE4

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

NCT00001757 ·Status: COMPLETED ·Phase: PHASE3

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

NCT00048750 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

NCT01982071 ·Status: TERMINATED ·Phase: PHASE4

Voriconazole to Prevent Systemic Fungal Infections in Children

NCT00005912 ·Status: COMPLETED ·Phase: PHASE1

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

NCT01344681 ·Status: COMPLETED ·Phase: PHASE2

Registry of Patients Treated With Systemic Mold-Active Triazoles

NCT03066011 ·Status: COMPLETED

A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis

NCT00002159 ·Status: COMPLETED ·Phase: PHASE3

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

NCT00059878 ·Status: COMPLETED ·Phase: PHASE2

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

NCT01686607 ·Status: COMPLETED

A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing

NCT01416025 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants

NCT03816176 ·Status: COMPLETED ·Phase: PHASE2

Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis

NCT00666185 ·Status: COMPLETED ·Phase: PHASE3